Association Between Cholinesterase Inhibitors and New-Onset Heart Failure in Patients With Alzheimer's Disease: A Nationwide Propensity Score Matching Study

BACKGROUND: Autonomic nervous dysfunction is a shared clinical feature in Alzheimer's disease (AD) and heart failure (HF). Cholinesterase inhibitors (ChEIs) are widely used autonomic modulators in patients with AD, but their primary preventive benefit on new-onset HF is still uncertain. OBJECTI...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsieh, Ming-Jer, Chen, Dong-Yi, Lee, Cheng-Hung, Wu, Chia-Ling, Chen, Ying-Jen, Huang, Yu-Tung, Chang, Shang-Hung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8966646/
https://www.ncbi.nlm.nih.gov/pubmed/35369359
http://dx.doi.org/10.3389/fcvm.2022.831730

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8966646/
https://www.ncbi.nlm.nih.gov/pubmed/35369359
http://dx.doi.org/10.3389/fcvm.2022.831730

Ejemplares similares